Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
15 2월 2024 - 6:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3) *
Enfusion,
Inc.
(Name of Issuer)
Class A common stock, par value $0.001 per
share
(Title of Class of Securities)
292812104
(CUSIP Number)
December 31, 2023
(Date of Event Which Requires Filing of this
Statement)
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
¨
Rule 13d-1(b)
¨
Rule 13d-1(c)
x
Rule 13d-1(d)
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP NO. 292812104
1 |
NAME OF REPORTING PERSONS
CSL Tech Holdings, LLC |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Nevada |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5 |
SOLE VOTING POWER
13,768,183 shares(1) |
6 |
SHARED VOTING POWER
0 |
7 |
SOLE DISPOSITIVE POWER
13,768,183 shares(1) |
8 |
SHARED DISPOSITIVE POWER
0 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,768,183 shares (1) |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (See Instructions) ¨
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.6%(2) |
12 |
TYPE OF REPORTING PERSON (See Instructions)
CO |
|
|
(1) |
Represents 1,151,818 shares of Class A common stock held directly by
CSL Tech Holdings, LLC and 12,616,365 shares of Class A common stock that CSL Tech Holdings, LLC has the right to acquire upon the exchange
of common units of Enfusion Ltd. LLC held by CSL Tech Holdings, LLC. |
|
|
(2) |
This
percentage calculation is based on 100,895,975 shares of Class A common stock outstanding, which is the sum of (i) 88,279,610 shares of
Class A common stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November
7, 2023, and (ii) the 12,616,365 shares of Class A common stock that CSL Tech Holdings, LLC has the right to acquire upon the exchange
of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A common stock outstanding pursuant to
Rule 13d-3(d)(1)(i)(D) under the Act.
|
CUSIP NO. 292812104
1 |
NAME OF REPORTING PERSONS
Oleg Movchan |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5 |
SOLE VOTING POWER
19,992 shares(3) |
6 |
SHARED VOTING POWER
13,768,183 shares (4) |
7 |
SOLE DISPOSITIVE POWER
19,992 shares(3) |
8 |
SHARED DISPOSITIVE POWER
13,768,183 shares (4) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,788,175 shares (3)(4) |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (See Instructions) ¨
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.7%(5) |
12 |
TYPE OF REPORTING PERSON (See Instructions)
IN |
(3) |
Represents
(i) 7,535 shares of Class A common stock issuable to Mr. Oleg Movchan upon the vesting of restricted stock units within 60 days of December
31, 2023, and (ii) 12,457 shares of Class A common stock underlying outstanding options held by Mr. Oleg Movchan that are exercisable
within 60 days of December 31, 2023. |
|
|
(4) |
Represents
(i) 1,151,818 shares of Class A common stock held directly by CSL Tech Holdings, LLC, and (ii) 12,616,365 shares of Class A common stock
that CSL Tech Holdings, LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC held by CSL Tech Holdings,
LLC. Mr. Movchan and his spouse, Ms. Vaynberg, may be deemed to have shared voting and dispositive power over such 1,151,818 shares of
Class A common stock held directly by CSL Tech Holdings, LLC and 12,616,365 shares of Class A common stock that CSL Tech Holdings, LLC
has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC held by CSL Tech Holdings, LLC. |
|
|
(5) |
This percentage calculation is based on 100,915,967
shares of Class A common stock outstanding, which is the sum of (i) 88,279,610 shares of Class A common stock outstanding as of November
5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, (ii) the 12,616,365 shares of Class
A common stock that CSL Tech Holdings, LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, (iii) 7,535
shares of Class A common stock issuable to Mr. Oleg Movchan upon the vesting of restricted stock units within 60 days of December 31,
2023, and (iv) 12,457 shares of Class A common stock underlying outstanding options held by Mr. Oleg Movchan that are exercisable within
60 days of December 31, 2023. The shares represented by (ii) through (iv) have been added to the total shares of Class A common stock
outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Act.
|
CUSIP
NO. 292812104
1 |
NAME OF REPORTING PERSONS
Beata Vaynberg |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5 |
SOLE VOTING POWER
0 |
6 |
SHARED VOTING POWER
13,768,183 shares (6) |
7 |
SOLE DISPOSITIVE POWER
0 |
8 |
SHARED DISPOSITIVE POWER
13,768,183 shares (6) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
13,768,183 shares (6) |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (See Instructions) ¨
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
13.6%(7) |
12 |
TYPE OF REPORTING PERSON (See Instructions)
IN |
(6) |
Represents
1,151,818 shares of Class A common stock held directly by CSL Tech Holdings, LLC and 12,616,365 shares of Class A common stock that CSL
Tech Holdings, LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC held by CSL Tech Holdings, LLC. Ms.
Vaynberg, and her spouse, Mr. Movchan, may be deemed to have shared voting and dispositive power over such 1,151,818 shares of Class A
common stock held directly by CSL Tech Holdings, LLC and 12,616,365 shares of Class A common stock that CSL Tech Holdings, LLC has the
right to acquire upon the exchange of common units of Enfusion Ltd. LLC held by CSL Tech Holdings, LLC. |
|
|
(7) |
This percentage calculation is based on 100,895,975
shares of Class A common stock outstanding, which is the sum of (i) 88,279,610 shares of Class A common stock outstanding as of November
5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, and (ii) the 12,616,365 shares of
Class A common stock that CSL Tech Holdings, LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which
shares have been added to the total shares of Class A common stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Act.
|
CUSIP NO. 292812104
Item 1(a). |
Name of Issuer: Enfusion, Inc. |
|
|
|
|
Item 1(b). |
Address of Issuer’s Principal Executive Offices: |
|
|
|
|
|
125 South Clark Street, Suite 750, Chicago, Illinois 60603 |
|
|
|
|
Item 2(a). |
Name of Person Filing: |
|
|
|
|
|
This statement is being jointly filed on behalf of CSL Tech Holdings, LLC, Mr. Oleg Movchan, and Ms. Beata Vaynberg. Each of the
foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This Schedule 13G/A
is being filed jointly by the Reporting Persons pursuant to an agreement of joint filing, a copy of which is attached hereto as Exhibit
99.1. Quiet Light Securities, LLC ceased to be the beneficial owner of the Class A common stock of Enfusion, Inc. in March of 2023,
and therefore is no longer included as a Reporting Person. |
|
|
|
|
Item 2(b). |
Address of Principal Business Office or, if none, Residence: |
|
|
|
|
|
The address of the principal business office of each of CSL Tech Holdings LLC, Mr. Movchan, and Ms. Vaynberg is 125 South Clark Street, Suite 750, Chicago, Illinois 60603. |
|
|
|
|
Item 2(c). |
Citizenship: |
|
|
|
|
|
CSL Tech Holdings, LLC is a Nevada limited liability company. |
|
|
|
|
|
Oleg Movchan is a citizen of United States. |
|
|
|
|
|
Beata Vaynberg is a citizen of the United States. |
|
|
|
|
Item 2(d). |
Title of Class of Securities: Class A common stock, par value $0.001 per share. |
|
|
|
|
Item 2(e). |
CUSIP Number: 292812104 |
|
|
|
|
Item 3. |
If this Statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
(a) |
☐ |
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); |
|
|
|
(b) |
☐ |
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); |
|
|
|
(c) |
☐ |
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); |
|
|
|
(d) |
☐ |
Investment company registered under Section 8 of the Investment Company Act of 1940 |
|
|
|
(e) |
☐ |
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
|
(f) |
☐ |
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
|
|
|
(g) |
☐ |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
|
|
|
(h) |
☐ |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
(i) |
☐ |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
|
|
|
(j) |
☐ |
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); |
(k) |
☐ |
Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
Item 4. |
Ownership |
|
|
|
Please see Items 5, 6, 7, 8, 9 and 11 of each cover sheet for each filing entity. |
|
|
Item 5. |
Ownership of Five Percent or Less of a Class |
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the following ¨. |
|
|
|
Not applicable. |
|
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
|
|
|
Not applicable. |
|
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person |
|
|
|
Not applicable. |
|
|
Item 8. |
Identification and Classification of Members of the Group |
|
|
|
Not applicable. |
Item 9. |
Notice of Dissolution of Group |
|
|
|
Not applicable. |
|
|
Item 10. |
Certification |
|
|
|
Not applicable. |
SIGNATURE
After reasonable inquiry
and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated this 14th day of February
2024
|
CSL
Tech Holdings, LLC |
|
|
|
By: |
/s/
Matthew Campobasso |
|
Matthew
Campobasso, as attorney-in-fact |
|
|
|
Oleg Movchan |
|
|
|
/s/ Matthew Campobasso |
|
Matthew
Campobasso, as attorney-in-fact |
|
|
|
Beata Vaynberg |
|
|
|
/s/ Beata Vaynberg |
EXHIBIT 99.1
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1)(iii) of the Securities
Exchange Act of 1934, as amended, each of the undersigned agree to the joint filing on behalf of each of them of the Statement on Schedule
13G filed herewith (and any amendments thereto), relating to the Class A common stock, par value $0.001 per share, of Enfusion, Inc.
This Joint Filing Agreement may be executed in
counterparts and each of such counterparts taken together shall constitute one and the same instrument.
Dated this 14th day of February 2024.
|
CSL
Tech Holdings, LLC |
|
|
|
By: |
/s/
Matthew Campobasso |
|
Matthew
Campobasso, as attorney-in-fact |
|
|
|
Oleg Movchan |
|
|
|
/s/
Matthew Campobasso |
|
Matthew
Campobasso, as attorney-in-fact |
|
|
|
Beata Vaynberg |
|
|
|
By: |
/s/ Beata Vaynberg |
Enfusion (NYSE:ENFN)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Enfusion (NYSE:ENFN)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024